TSMC Sees 5G Driving Strong Demand for 7nm
By Alan Patterson, EETimes
July 22, 2019
Taiwan Semiconductor Manufacturing Co. (TSMC) sees 5-nm and 7-nm demand improving from its earlier expectations, as the worldwide 5G development accelerates.
Demand is so strong that the company is preparing to raise its full-year capital expenditure to more than $11 billion, the high end of its target at the beginning of 2019, TSMC said in its second-quarter results.
TSMC said it may need to increase 2019 capex to accelerate the installation of tools for 5nm production next year.
The company's most advanced 7nm node is poised to become its new cash cow, as it accounted for 21% of revenue in the second quarter, compared with 10nm at 3% and 16nm at 23%. Those three nodes made up 47% of total sales, increasing from 42% in the first quarter.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Related News
- TSMC Sees HPC Driving Business
- TSMC sees Q3 demand as it solidifies roadmap
- Andes Technology Achieves Record Annual Revenue Amid Strong AI Demand
- Achronix Releases Groundbreaking Speedster AC7t800 Mid-Range FPGA, Driving Innovation in AI/ML, 5G/6G and Data Center Applications
- Driving Europe's Chip Renaissance: TSMC's Vision with ESMC
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design